Interleukin-17A immune pattern across genetic acantholytic and blistering disorders

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Acantholytic and blistering genodermatoses present significant therapeutic challenges.
• Cutaneous inflammation is a key factor, but its specific patterns require further elucidation.
• Interleukin-17A (IL-17A) is a cytokine implicated in inflammatory processes.

Purpose of the Study:

• To investigate the expression of IL-17A in the inflammatory infiltrate of patients with specific genodermatoses.
• To determine if IL-17A plays a role in the pathogenesis of Hailey-Hailey disease, Darier disease, and epidermolysis bullosa.
• To explore IL-17A as a potential therapeutic target.

Main Methods:

• Immunohistochemistry was used to detect IL-17A-positive cells in skin biopsies from 34 patients.
• Patients included those with Hailey-Hailey disease, Darier disease, junctional epidermolysis bullosa, and dystrophic epidermolysis bullosa.
• Upregulation of downstream genes/proteins (S100A7, S100A8, S100A9) was assessed to validate the IL-17A inflammatory pattern.

Main Results:

• A 5-7 fold increase in IL-17A-positive cells was observed in patient samples compared to normal skin.
• IL-17A cells were localized to epidermal acantholytic areas and dermal infiltrates in Hailey-Hailey and Darier disease.
• In epidermolysis bullosa, IL-17A-positive cells were found at the dermoepidermal junction zone.
• Upregulation of S100 calcium-binding proteins confirmed the IL-17A-driven inflammatory response.

Conclusions:

• IL-17A is significantly expressed in the inflammatory infiltrates of Hailey-Hailey disease, Darier disease, and epidermolysis bullosa.
• The presence and localization of IL-17A suggest its contribution to skin inflammation in these conditions.
• IL-17A emerges as a potential therapeutic target for managing inflammatory flares in these genodermatoses.